2018 Grant Recipients

Grant applications were assessed by our Scientific Advisory Panel - comprised of international and national experts in the area. The panel made recommendations to the board as to who the successful applicants should be and these were accepted unanimously.

Innovation Grant

Malaria protein VAR2CSA-based CAR-T cells directed against oncofetal glycosaminoglycans to mediate remission in Pancreatic Cancer. An update to this grant status is provided below.
Dual targeting of metabolic and immunological aberrations in Pancreatic Cancer
Personalised Immunotherapy for Pancreatic Cancer
Starvation of pancreatic tumours by metabolically reprogramming both tumour and stromal cells